{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T17:50:46Z","timestamp":1790013046025,"version":"4.0.1"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T00:00:00Z","timestamp":1736553600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T00:00:00Z","timestamp":1736553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004775","name":"Natural Science Foundation of Gansu Province","doi-asserted-by":"crossref","award":["no. 23JRRA1291"],"award-info":[{"award-number":["no. 23JRRA1291"]}],"id":[{"id":"10.13039\/501100004775","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004775","name":"Natural Science Foundation of Gansu Province","doi-asserted-by":"crossref","award":["no. 23JRRA1291"],"award-info":[{"award-number":["no. 23JRRA1291"]}],"id":[{"id":"10.13039\/501100004775","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004775","name":"Natural Science Foundation of Gansu Province","doi-asserted-by":"crossref","award":["no. 23JRRA1291"],"award-info":[{"award-number":["no. 23JRRA1291"]}],"id":[{"id":"10.13039\/501100004775","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004775","name":"Natural Science Foundation of Gansu Province","doi-asserted-by":"crossref","award":["no. 23JRRA1291"],"award-info":[{"award-number":["no. 23JRRA1291"]}],"id":[{"id":"10.13039\/501100004775","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004775","name":"Natural Science Foundation of Gansu Province","doi-asserted-by":"crossref","award":["no. 23JRRA1291"],"award-info":[{"award-number":["no. 23JRRA1291"]}],"id":[{"id":"10.13039\/501100004775","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004775","name":"Natural Science Foundation of Gansu Province","doi-asserted-by":"crossref","award":["no. 23JRRA1291"],"award-info":[{"award-number":["no. 23JRRA1291"]}],"id":[{"id":"10.13039\/501100004775","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004775","name":"Natural Science Foundation of Gansu Province","doi-asserted-by":"crossref","award":["no. 23JRRA1291"],"award-info":[{"award-number":["no. 23JRRA1291"]}],"id":[{"id":"10.13039\/501100004775","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"DOI":"10.1186\/s13014-024-02580-w","type":"journal-article","created":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T04:17:21Z","timestamp":1736569041000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Efficacy and safety of proton radiotherapy in treating choroidal melanoma: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"20","author":[{"given":"Yuxin","family":"Miao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingwei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuning","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meixuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qihang","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongtao","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiling","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,11]]},"reference":[{"issue":"2","key":"2580_CR1","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1080\/0284186X.2020.1820572","volume":"60","author":"K EIBENBERGER","year":"2021","unstructured":"Eibenberger K, Dunavoelgyi R, Gleiss A, et al. Hypofractionated stereotactic photon radiotherapy of choroidal melanoma: 20-year experience [J]. Acta Oncol. 2021;60(2):207\u201314.","journal-title":"Acta Oncol"},{"issue":"5","key":"2580_CR2","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/S0161-6420(03)00078-2","volume":"110","author":"TOPHAMA SINGH A D","year":"2003","unstructured":"Singh A D Tophama. Incidence of uveal melanoma in the United States: 1973\u20131997 [J]. Ophthalmology. 2003;110(5):956\u201361.","journal-title":"Ophthalmology"},{"issue":"9","key":"2580_CR3","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1016\/j.ophtha.2011.01.040","volume":"118","author":"SINGH A D","year":"2011","unstructured":"Singh A D, Turell M E, Topham A K. Uveal melanoma: trends in incidence, treatment, and survival [J]. Ophthalmology. 2011;118(9):1881\u20135.","journal-title":"Ophthalmology"},{"issue":"11","key":"2580_CR4","doi-asserted-by":"publisher","first-page":"4651","DOI":"10.1167\/iovs.03-0538","volume":"44","author":"E KUJALA","year":"2003","unstructured":"Kujala E, M\u00e4kitie T, Kivel\u00e4 T. Very long-term prognosis of patients with malignant uveal melanoma [J]. Invest Ophthalmol Vis Sci. 2003;44(11):4651\u20139.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"2580_CR5","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1016\/j.ophtha.2013.03.012","volume":"120","author":"L SHIELDS C","year":"2013","unstructured":"Shields C L, Kaliki S, Furuta M, et al. American Joint Committee on Cancer classification of posterior uveal melanoma (tumor size category) predicts prognosis in 7731 patients [J]. Ophthalmology. 2013;120(10):2066\u201371.","journal-title":"Ophthalmology"},{"issue":"03","key":"2580_CR6","first-page":"313","volume":"22","author":"YUE H","year":"2022","unstructured":"Yue H, Qian J. Comparison between plaque radiotherapy and charged particle radiotherapy in uveal melanoma [J]. Chin J Ophthalmol Otorhinolaryngol. 2022;22(03):313\u20136.","journal-title":"Chin J Ophthalmol Otorhinolaryngol"},{"issue":"06","key":"2580_CR7","first-page":"1060","volume":"59","author":"C LIU S,WANG S,LI","year":"2024","unstructured":"Liu S, Wang S, Li C. Develop and validate a predictive model for overall survival and fumor-specific survival in patients with choroidal melanoma [J]. Acta Universitatis Medicinalis Anhui. 2024;59(06):1060\u20137.","journal-title":"Acta Universitatis Medicinalis Anhui"},{"issue":"Suppl 20","key":"2580_CR8","doi-asserted-by":"publisher","first-page":"S186","DOI":"10.1097\/BRS.0000000000001831","volume":"41","author":"B PENNICOOKE","year":"2016","unstructured":"Pennicooke B, Laufer I. Safety and Local Control of Radiation Therapy for Chordoma of the spine and sacrum: a systematic review [J]. Spine (Phila Pa 1976). 2016;41(Suppl 20):S186\u201392.","journal-title":"Spine (Phila Pa 1976)"},{"issue":"7","key":"2580_CR9","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1136\/bjo.72.7.494","volume":"72","author":"ADAMS K S","year":"1988","unstructured":"Adams K S, Abramson D H, Ellsworth R M, et al. Cobalt plaque versus enucleation for uveal melanoma: comparison of survival rates [J]. Br J Ophthalmol. 1988;72(7):494\u20137.","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"2580_CR10","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/S0161-6420(90)32512-5","volume":"97","author":"JM SEDDON","year":"1990","unstructured":"Seddon JM, Gragoudas E S, Egan K M, et al. Relative survival rates after alternative therapies for uveal melanoma [J]. Ophthalmology. 1990;97(6):769\u201377.","journal-title":"Ophthalmology"},{"issue":"9","key":"2580_CR11","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1016\/S0161-6420(98)99037-6","volume":"105","author":"AUGSBURGERJJ CORR\u00eaA","year":"1998","unstructured":"Augsburger JJ, Corr\u00eaa ZM, Freire J. Long-term survival in choroidal and ciliary body melanoma after enucleation versus plaque radiation therapy [J]. Ophthalmology. 1998;105(9):1670\u20138.","journal-title":"Ophthalmology"},{"issue":"12","key":"2580_CR12","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1001\/archopht.124.12.1684","volume":"124","author":"The COMS randomized trial of","year":"2006","unstructured":"The COMS randomized trial of. Iodine 125 brachytherapy for choroidal melanoma: V. twelve-year mortality rates and prognostic factors: COMS report 28 [J]. Arch Ophthalmol. 2006;124(12):1684\u201393.","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"2580_CR13","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/S0360-3016(03)00006-3","volume":"56","author":"S NAG","year":"2003","unstructured":"Nag S, Quivey J M, Earle JD, et al. The American Brachytherapy Society recommendations for brachytherapy of uveal melanomas [J]. Int J Radiat Oncol Biol Phys. 2003;56(2):544\u201355.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"2580_CR14","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/S0161-6420(82)34658-8","volume":"89","author":"SHIELDS J A","year":"1982","unstructured":"Shields J A, Augsburger J J, Brady L W, et al. Cobalt plaque therapy of posterior uveal melanomas [J]. Ophthalmology. 1982;89(10):1201\u20137.","journal-title":"Ophthalmology"},{"issue":"11","key":"2580_CR15","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1001\/archopht.1991.01080110148053","volume":"109","author":"FINGER P","year":"1991","unstructured":"Finger P, T, Moshfeghi D M. Ho T K. Palladium 103 ophthalmic plaque radiotherapy [J]. Arch Ophthalmol. 1991;109(11):1610\u20133.","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"2580_CR16","first-page":"135","volume":"20","author":"S PACKER","year":"1980","unstructured":"Packer S. Radiotherapy of choroidal melanoma with iodine 125 [J]. Int Ophthalmol Clin. 1980;20(2):135\u201342.","journal-title":"Int Ophthalmol Clin"},{"issue":"2","key":"2580_CR17","first-page":"85","volume":"19","author":"LOMMATZSCH P","year":"1974","unstructured":"Lommatzsch P. Treatment of choroidal melanomas with 106Ru\/106Rh beta-ray applicators [J]. Surv Ophthalmol. 1974;19(2):85\u2013100.","journal-title":"Surv Ophthalmol"},{"issue":"10","key":"2580_CR18","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1016\/S0161-6420(02)01174-0","volume":"109","author":"S CHAR D H, KROLL","year":"2002","unstructured":"Char D H, Kroll S, Phillips T L, et al. Late radiation failures after iodine 125 brachytherapy for uveal melanoma compared with charged-particle (proton or Helium ion) therapy [J]. Ophthalmology. 2002;109(10):1850\u20134.","journal-title":"Ophthalmology"},{"issue":"8","key":"2580_CR19","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1200\/JCO.2006.09.7816","volume":"25","author":"H SCHULZ-ERTNER D, TSUJII","year":"2007","unstructured":"Schulz-Ertner D, Tsujii H. Particle radiation therapy using proton and heavier ion beams [J]. J Clin Oncol. 2007;25(8):953\u201364.","journal-title":"J Clin Oncol"},{"issue":"2","key":"2580_CR20","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1167\/iovs.16-20212","volume":"58","author":"M DOGRUS\u00f6Z","year":"2017","unstructured":"Dogrus\u00f6z M, Bagger M, van Duinen S G, et al. The Prognostic Value of AJCC staging in Uveal Melanoma is enhanced by adding chromosome 3 and 8q status [J]. Invest Ophthalmol Vis Sci. 2017;58(2):833\u201342.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"2580_CR21","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1159\/000492391","volume":"5","author":"C BAILY","year":"2019","unstructured":"Baily C, O\u2019Neill V, Dunnem M, et al. Uveal Melanoma in Ireland [J]. Ocul Oncol Pathol. 2019;5(3):195\u2013204.","journal-title":"Ocul Oncol Pathol"},{"issue":"5","key":"2580_CR22","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1136\/bjophthalmol-2019-314802","volume":"105","author":"R HUSSAIN","year":"2021","unstructured":"Hussain R, Heussen F M Heimannh. OCT changes in peri-tumour normal retina following ruthenium-106 and proton beam radiotherapy for uveal melanoma [J]. Br J Ophthalmol. 2021;105(5):648\u201352.","journal-title":"Br J Ophthalmol"},{"issue":"12","key":"2580_CR23","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s00066-005-1395-6","volume":"181","author":"S H\u00f6CHT","year":"2005","unstructured":"H\u00f6cht S, Stark R, Seiler F, et al. Proton or stereotactic photon irradiation for posterior uveal melanoma? A planning intercomparison [J]. Strahlenther Onkol. 2005;181(12):783\u20138.","journal-title":"Strahlenther Onkol"},{"issue":"4","key":"2580_CR24","first-page":"989","volume":"2","author":"M KOUTSANDREA C, MOSCHOS M M, DIMISSI","year":"2008","unstructured":"Koutsandrea C, Moschos M M, Dimissianos M, et al. Metastasis rates and sites after treatment for choroidal melanoma by proton beam irradiation or by enucleation [J]. Clin Ophthalmol. 2008;2(4):989\u201395.","journal-title":"Clin Ophthalmol"},{"issue":"7","key":"2580_CR25","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1136\/bjo.68.7.479","volume":"68","author":"M GRAGOUDAS E S, GOITEIN","year":"1984","unstructured":"Gragoudas E S, Goitein M, Seddon J, et al. Preliminary results of proton beam irradiation of macular and paramacular melanomas [J]. Br J Ophthalmol. 1984;68(7):479\u201385.","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"2580_CR26","first-page":"359","volume":"18","author":"SAS-KORCZY\u0143SKA B","year":"2014","unstructured":"Sas-Korczy\u0144ska B, Markiewicz A, Romanowska-Dixon B, et al. Preliminary results of proton radiotherapy for choroidal melanoma - the Krak\u00f3w experience [J]. Contemp Oncol (Pozn). 2014;18(5):359\u201366.","journal-title":"Contemp Oncol (Pozn)"},{"key":"2580_CR27","unstructured":"Yang K. Evidence-based Social Science: the origin, development and prospects. Library & Information; 2018. pp. 1\u201310. 03."},{"issue":"1","key":"2580_CR28","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ijrobp.2012.08.026","volume":"86","author":"Z WANG","year":"2013","unstructured":"Wang Z, Nabhan M. Charged particle radiation therapy for uveal melanoma: a systematic review and meta-analysis [J]. Int J Radiat Oncol Biol Phys. 2013;86(1):18\u201326.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2580_CR29","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jclinepi.2021.02.021","volume":"135","author":"Y LI","year":"2021","unstructured":"Li Y, Cao L, Zhang Z, et al. Reporting and methodological quality of COVID-19 systematic reviews needs to be improved: an evidence mapping [J]. J Clin Epidemiol. 2021;135:17\u201328.","journal-title":"J Clin Epidemiol"},{"key":"2580_CR30","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jclinepi.2021.09.014","volume":"141","author":"X LI","year":"2022","unstructured":"Li X, Li Y, Guo K, et al. Evidence based Social Science in China Paper 3: the quality of social science RCTs published from 2000\u20132020 [J]. J Clin Epidemiol. 2022;141:64\u201373.","journal-title":"J Clin Epidemiol"},{"key":"2580_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jclinepi.2022.11.004","volume":"153","author":"Y WANG","year":"2023","unstructured":"Wang Y, Chen N, Guo K, et al. Reporting and methodological quality of acupuncture network meta-analyses could be improved: an evidence mapping [J]. J Clin Epidemiol. 2023;153:1\u201312.","journal-title":"J Clin Epidemiol"},{"issue":"7","key":"2580_CR32","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D MOHER","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement [J]. PLoS Med. 2009;6(7):e1000097.","journal-title":"PLoS Med"},{"issue":"2","key":"2580_CR33","doi-asserted-by":"publisher","first-page":"335","DOI":"10.4143\/crt.2017.070","volume":"50","author":"CHOIE KIM T W","year":"2018","unstructured":"Kim T W, Choi E, Park J, et al. Clinical outcomes of Proton Beam Therapy for Choroidal Melanoma at a Single Institute in Korea [J]. Cancer Res Treat. 2018;50(2):335\u201344.","journal-title":"Cancer Res Treat"},{"issue":"4","key":"2580_CR34","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1159\/000334401","volume":"227","author":"C MOSCI","year":"2012","unstructured":"Mosci C, Lanza F B, Barla A, et al. Comparison of clinical outcomes for patients with large choroidal melanoma after primary treatment with enucleation or proton beam radiotherapy [J]. Ophthalmologica. 2012;227(4):190\u20136.","journal-title":"Ophthalmologica"},{"issue":"11","key":"2580_CR35","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1001\/jamaophthalmol.2017.3805","volume":"135","author":"M PAPAKOSTAS T D, LANE A M, MORRISON","year":"2017","unstructured":"Papakostas T D, Lane A M, Morrison M, et al. Long-term outcomes after Proton Beam Irradiation in patients with large choroidal melanomas [J]. JAMA Ophthalmol. 2017;135(11):1191\u20136.","journal-title":"JAMA Ophthalmol"},{"key":"2580_CR36","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.ajo.2016.02.027","volume":"165","author":"E BENSOUSSAN","year":"2016","unstructured":"Bensoussan E, Thariat J, Maschi C, et al. Outcomes after Proton Beam Therapy for Large Choroidal Melanomas in 492 patients [J]. Am J Ophthalmol. 2016;165:78\u201387.","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"2580_CR37","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1016\/j.ijrobp.2011.10.017","volume":"83","author":"E TRAN","year":"2012","unstructured":"Tran E, Ma R, Paton K, et al. Outcomes of proton radiation therapy for peripapillary choroidal melanoma at the BC Cancer Agency [J]. Int J Radiat Oncol Biol Phys. 2012;83(5):1425\u201331.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"2580_CR38","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/S0360-3016(00)01430-9","volume":"49","author":"M FUSS","year":"2001","unstructured":"Fuss M, Loredo L N, Blacharski PA, et al. Proton radiation therapy for medium and large choroidal melanoma: preservation of the eye and its functionality [J]. Int J Radiat Oncol Biol Phys. 2001;49(4):1053\u20139.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2580_CR39","doi-asserted-by":"publisher","unstructured":"Wang Xiaoqin CY, Qingyuan Q, Yang K. Interpretation of Methodological Quality Assessment Tools for Case Series Research. Chin J Evidence-Based Pediatr 10(5). https:\/\/doi.org\/10.3969\/j.issn.1673-5501.2015.05.012","DOI":"10.3969\/j.issn.1673-5501.2015.05.012"},{"issue":"8","key":"2580_CR40","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.1016\/j.clon.2016.01.034","volume":"28","author":"V VERMA","year":"2016","unstructured":"Verma V, Mehta MP. Clinical outcomes of Proton Radiotherapy for Uveal Melanoma [J]. Clin Oncol (R Coll Radiol). 2016;28(8):e17\u201327.","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"3","key":"2580_CR41","doi-asserted-by":"publisher","first-page":"635","DOI":"10.4143\/crt.2021.706","volume":"53","author":"JM PARK","year":"2021","unstructured":"Park JM, Kim JI, Wu HG. Technological advances in charged-particle therapy [J]. Cancer Res Treat. 2021;53(3):635\u201340.","journal-title":"Cancer Res Treat"},{"issue":"4","key":"2580_CR42","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.ajo.2015.06.017","volume":"160","author":"I SEIBEL","year":"2015","unstructured":"Seibel I, Cordini D, Rehak M, et al. Local recurrence after primary Proton Beam Therapy in Uveal Melanoma: risk factors, Retreatment approaches, and outcome [J]. Am J Ophthalmol. 2015;160(4):628\u201336.","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"2580_CR43","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/nrc.2016.18","volume":"16","author":"M BAUMANN","year":"2016","unstructured":"Baumann M, Krause M, Overgaard J, et al. Radiation oncology in the era of precision medicine [J]. Nat Rev Cancer. 2016;16(4):234\u201349.","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"2580_CR44","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.semradonc.2006.04.008","volume":"16","author":"O SCHULZ-ERTNER D, J\u00e4KEL","year":"2006","unstructured":"Schulz-Ertner D, J\u00e4kel O. Radiation therapy with charged particles [J]. Semin Radiat Oncol. 2006;16(4):249\u201359.","journal-title":"Semin Radiat Oncol"},{"key":"2580_CR45","doi-asserted-by":"crossref","unstructured":"Tsujii H, Mizoe J, Kamada T et al. Clinical Results of Carbon Ion Radiotherapy at NIRS [J]. J Radiat Res, 2007, 48 Suppl A: A1-a13.","DOI":"10.1269\/jrr.48.A1"},{"issue":"10","key":"2580_CR46","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1093\/jjco\/hyw102","volume":"46","author":"H SAKURAI","year":"2016","unstructured":"Sakurai H, Ishikawa H, Okumura T. Proton Beam therapy in Japan: current and future status [J]. Jpn J Clin Oncol. 2016;46(10):885\u201392.","journal-title":"Jpn J Clin Oncol"},{"issue":"2","key":"2580_CR47","first-page":"120","volume":"18","author":"P KUMAR R. NCCN Guidelines Insights","year":"2020","unstructured":"P Kumar R. NCCN Guidelines Insights. Uveal melanoma, Version 1.2019 [J]. J Natl Compr Cancer Network: JNCCN. 2020;18(2):120\u201331.","journal-title":"J Natl Compr Cancer Network: JNCCN"},{"issue":"7","key":"2580_CR48","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1001\/archopht.119.7.969","volume":"119","author":"SL DIENER-WEST M, EARLE J D, FINE","year":"2001","unstructured":"Diener-West M, Earle J D, Fine SL, et al. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: initial mortality findings. COMS Report 18 [J]. Arch Ophthalmol. 2001;119(7):969\u201382.","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"2580_CR49","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.ophtha.2011.08.017","volume":"119","author":"FINGER P T","year":"2012","unstructured":"Finger P T, Chin K J. Tena L B. A five-year study of slotted eye plaque radiation therapy for choroidal melanoma: near, touching, or surrounding the optic nerve [J]. Ophthalmology. 2012;119(2):415\u201322.","journal-title":"Ophthalmology"},{"issue":"6","key":"2580_CR50","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/j.brachy.2017.07.014","volume":"16","author":"S LIN A J, RAO Y J, ACHARYA","year":"2017","unstructured":"Lin A J, Rao Y J, Acharya S, et al. Patterns of care and outcomes of proton and eye plaque brachytherapy for uveal melanoma: review of the National Cancer database [J]. Brachytherapy. 2017;16(6):1225\u201331.","journal-title":"Brachytherapy"},{"issue":"6","key":"2580_CR51","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.brachy.2014.04.002","volume":"13","author":"BARKER C A","year":"2014","unstructured":"Barker C A, Francis J H, Cohen G N, et al. (106)Ru plaque brachytherapy for uveal melanoma: factors associated with local tumor recurrence [J]. Brachytherapy. 2014;13(6):584\u201390.","journal-title":"Brachytherapy"},{"issue":"11","key":"2580_CR52","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1016\/S1470-2045(20)30459-9","volume":"21","author":"T PARKER","year":"2020","unstructured":"Parker T, Rigney G, Kallos J, et al. Gamma knife radiosurgery for uveal melanomas and metastases: a systematic review and meta-analysis [J]. Lancet Oncol. 2020;21(11):1526\u201336.","journal-title":"Lancet Oncol"},{"key":"2580_CR53","doi-asserted-by":"crossref","unstructured":"Packer S, Stoller S, Lesser M L et al. Long-term results of iodine 125 irradiation of uveal melanoma [J]. Ophthalmology, 1992, 99(5): 767\u2009\u2013\u200973; discussion 74.","DOI":"10.1016\/S0161-6420(92)31899-8"},{"issue":"11","key":"2580_CR54","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1001\/archopht.1996.01100140557006","volume":"114","author":"JA DE POTTER P, SHIELDS C L, SHIELDS","year":"1996","unstructured":"de Potter P, Shields C L, Shields JA, et al. Plaque radiotherapy for juxtapapillary choroidal melanoma. Visual acuity and survival outcome [J]. Arch Ophthalmol. 1996;114(11):1357\u201365.","journal-title":"Arch Ophthalmol"},{"issue":"8","key":"2580_CR55","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1007\/BF00195358","volume":"232","author":"PK LOMMATZSCH","year":"1994","unstructured":"Lommatzsch PK, Alberti W, Lommatzsch R, et al. Radiation effects on the optic nerve observed after brachytherapy of choroidal melanomas with 106Ru\/106Rh plaques [J]. Graefes Arch Clin Exp Ophthalmol. 1994;232(8):482\u20137.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"4","key":"2580_CR56","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/S0360-3016(01)02723-7","volume":"52","author":"R JONES","year":"2002","unstructured":"Jones R, Gore E, Mieler W, et al. Posttreatment visual acuity in patients treated with episcleral plaque therapy for choroidal melanomas: dose and dose rate effects [J]. Int J Radiat Oncol Biol Phys. 2002;52(4):989\u201395.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2580_CR57","doi-asserted-by":"crossref","unstructured":"Thomas G N, Chou IL, Gopal L. Plaque radiotherapy for ocular melanoma [J]. Cancers (Basel), 2024, 16(19).","DOI":"10.3390\/cancers16193386"},{"issue":"3","key":"2580_CR58","doi-asserted-by":"publisher","first-page":"358","DOI":"10.5114\/jcb.2021.106191","volume":"13","author":"S KARIMI","year":"2021","unstructured":"Karimi S, Arabi A, Siavashpour Z, et al. Efficacy and complications of ruthenium-106 brachytherapy for uveal melanoma: a systematic review and meta-analysis [J]. J Contemp Brachytherapy. 2021;13(3):358\u201364.","journal-title":"J Contemp Brachytherapy"},{"key":"2580_CR59","doi-asserted-by":"crossref","unstructured":"Gallo B, Hussain R, Al-Jamal R et al. Local tumour control and patient survival after ruthenium-106 brachytherapy for small choroidal melanoma [J]. Br J Ophthalmol, 2024.","DOI":"10.1136\/bjo-2023-324687"},{"key":"2580_CR60","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.radonc.2021.11.007","volume":"166","author":"F BUONANNO","year":"2022","unstructured":"Buonanno F, Conson M, de Almeida Ribeiro C, et al. Local tumor control and treatment related toxicity after plaque brachytherapy for uveal melanoma: a systematic review and a data pooled analysis [J]. Radiother Oncol. 2022;166:15\u201325.","journal-title":"Radiother Oncol"},{"issue":"1","key":"2580_CR61","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1097\/COC.0000000000000775","volume":"44","author":"S KOSYDAR","year":"2021","unstructured":"Kosydar S, Robertson J C, Woodfin M, et al. Systematic review and Meta-analysis on the Use of Photon-based stereotactic Radiosurgery Versus fractionated Stereotactic Radiotherapy for the Treatment of Uveal Melanoma [J]. Am J Clin Oncol. 2021;44(1):32\u201342.","journal-title":"Am J Clin Oncol"},{"issue":"4","key":"2580_CR62","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s00066-009-1900-4","volume":"185","author":"VLASSOVVV BEKKERING G E, RUTJES A W","year":"2009","unstructured":"Bekkering G E, Rutjes A W Vlassovvv, et al. The effectiveness and safety of proton radiation therapy for indications of the eye: a systematic review [J]. Strahlenther Onkol. 2009;185(4):211\u201321.","journal-title":"Strahlenther Onkol"},{"issue":"2","key":"2580_CR63","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0002-9394(14)73868-1","volume":"119","author":"SM GRAGOUDAS E S, EGAN K M, WALSH","year":"1995","unstructured":"Gragoudas E S, Egan K M, Walsh SM, et al. Lens changes after proton beam irradiation for uveal melanoma [J]. Am J Ophthalmol. 1995;119(2):157\u201364.","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"2580_CR64","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1007\/s00417-016-3356-4","volume":"254","author":"I SEIBEL","year":"2016","unstructured":"Seibel I, Cordini D. Cataract development in patients treated with proton beam therapy for uveal melanoma [J]. Graefes Arch Clin Exp Ophthalmol. 2016;254(8):1625\u201330.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2580_CR65","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.ajo.2017.03.027","volume":"178","author":"J SEIBEL I, RIECHARDT A I, HEUFELDER","year":"2017","unstructured":"Seibel I, Riechardt A I, Heufelder J, et al. Adjuvant ab interno Tumor Treatment after Proton Beam irradiation [J]. Am J Ophthalmol. 2017;178:94\u2013100.","journal-title":"Am J Ophthalmol"},{"issue":"10","key":"2580_CR66","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.bulcan.2018.07.011","volume":"105","author":"T MATHIS","year":"2018","unstructured":"Mathis T, Cassoux N, Tardy M, et al. [Management of uveal melanomas, guidelines for oncologists] [J]. Bull Cancer. 2018;105(10):967\u201380.","journal-title":"Bull Cancer"},{"issue":"5","key":"2580_CR67","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/S0360-3016(97)00557-9","volume":"39","author":"DAFTARI I K","year":"1997","unstructured":"Daftari I K, Char D H, Verhey L J, et al. Anterior segment sparing to reduce charged particle radiotherapy complications in uveal melanoma [J]. Int J Radiat Oncol Biol Phys. 1997;39(5):997\u20131010.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"2580_CR68","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.ijrobp.2013.05.051","volume":"87","author":"WEINBERGV MISHRA K K, DAFTARI I K","year":"2013","unstructured":"Mishra K K, Daftari I K Weinbergv, et al. Risk factors for neovascular glaucoma after proton beam therapy of uveal melanoma: a detailed analysis of tumor and dose-volume parameters [J]. Int J Radiat Oncol Biol Phys. 2013;87(2):330\u20136.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"7","key":"2580_CR69","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1007\/s11864-024-01212-5","volume":"25","author":"F YILMAZ M T, SARI S Y, ZORLU","year":"2024","unstructured":"Yilmaz M T, Sari S Y, Zorlu F, et al. External Beam Radiotherapy in the management of Uveal Melanoma [J]. Curr Treat Options Oncol. 2024;25(7):932\u201351.","journal-title":"Curr Treat Options Oncol"},{"issue":"11","key":"2580_CR70","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.1007\/s00417-020-04780-y","volume":"258","author":"A RIECHARDT A I, STROUX","year":"2020","unstructured":"Riechardt A I, Stroux A, Seibel I, et al. Side effects of proton beam therapy of choroidal melanoma in dependence of the dose to the optic disc and the irradiated length of the optic nerve [J]. Graefes Arch Clin Exp Ophthalmol. 2020;258(11):2523\u201333.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2580_CR71","doi-asserted-by":"crossref","unstructured":"Gragoudas ES, Li W, Lane AM et al. Risk factors for radiation maculopathy and papillopathy after intraocular irradiation [J]. Ophthalmology, 1999, 106(8): 1571-7; discussion 7\u20138.","DOI":"10.1016\/S0161-6420(99)90455-4"},{"issue":"1","key":"2580_CR72","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/S0161-6420(96)30752-5","volume":"103","author":"SS PARK","year":"1996","unstructured":"Park SS, Walsh S M, Gragoudas E S. Visual-field deficits associated with proton beam irradiation for parapapillary choroidal melanoma [J]. Ophthalmology. 1996;103(1):110\u20136.","journal-title":"Ophthalmology"},{"issue":"9","key":"2580_CR73","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1007\/s00417-018-4036-3","volume":"256","author":"C BUSCH","year":"2018","unstructured":"Busch C, L\u00f6wen J, Pilger D, et al. Quantification of radiation retinopathy after beam proton irradiation in centrally located choroidal melanoma [J]. Graefes Arch Clin Exp Ophthalmol. 2018;256(9):1599\u2013604.","journal-title":"Graefes Arch Clin Exp Ophthalmol"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-024-02580-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13014-024-02580-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-024-02580-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T06:03:56Z","timestamp":1736575436000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-024-02580-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,11]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2580"],"URL":"https:\/\/doi.org\/10.1186\/s13014-024-02580-w","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,11]]},"assertion":[{"value":"4 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7"}}